Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
23.22
+0.71 (3.15%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cidara Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 127.39 | 35.78 | 32.73 | 59.68 | 35.91 | 50.27 | Upgrade
|
| Cash & Short-Term Investments | 127.39 | 35.78 | 32.73 | 59.68 | 35.91 | 50.27 | Upgrade
|
| Cash Growth | 161.73% | 9.31% | -45.16% | 66.18% | -28.56% | -32.58% | Upgrade
|
| Accounts Receivable | 1.7 | 16.25 | 5.83 | 5.36 | 11.18 | 0.01 | Upgrade
|
| Receivables | 1.7 | 16.25 | 5.83 | 5.36 | 11.18 | 0.01 | Upgrade
|
| Inventory | - | 6.1 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 27.69 | 2.73 | 6.53 | 4.07 | 3.07 | 5.54 | Upgrade
|
| Restricted Cash | - | - | - | 2.59 | 7.04 | 10 | Upgrade
|
| Total Current Assets | 156.77 | 60.86 | 45.09 | 71.7 | 57.19 | 65.81 | Upgrade
|
| Property, Plant & Equipment | 4.32 | 5.13 | 1.32 | 2.54 | 1.21 | 2.06 | Upgrade
|
| Other Long-Term Assets | 1.24 | 1.05 | 1.07 | 1.08 | 2.02 | 1.1 | Upgrade
|
| Total Assets | 162.33 | 67.03 | 47.49 | 75.33 | 60.42 | 68.98 | Upgrade
|
| Accounts Payable | 2.97 | 3.77 | 1.45 | 1.3 | 4.57 | 1.89 | Upgrade
|
| Accrued Expenses | 39.79 | 37.25 | 24.13 | 15.06 | 12.17 | 7.73 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 2.59 | 7.02 | 9.97 | Upgrade
|
| Current Portion of Leases | 1.58 | 1.3 | 1.21 | 1.15 | 0.94 | 0.82 | Upgrade
|
| Current Unearned Revenue | - | 25.1 | 14.61 | 13.92 | 13.87 | 9.8 | Upgrade
|
| Total Current Liabilities | 44.34 | 67.42 | 41.4 | 34.02 | 38.56 | 30.2 | Upgrade
|
| Long-Term Leases | 2.36 | 3.58 | - | 1.32 | - | 0.94 | Upgrade
|
| Long-Term Unearned Revenue | - | 4.25 | 20.53 | 18.41 | 11.15 | - | Upgrade
|
| Total Liabilities | 46.7 | 75.24 | 61.93 | 53.75 | 49.71 | 31.14 | Upgrade
|
| Common Stock | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 674.58 | 433.21 | 404.06 | 398.73 | 345.41 | 297.66 | Upgrade
|
| Retained Earnings | -558.95 | -441.43 | -418.5 | -377.17 | -334.7 | -259.83 | Upgrade
|
| Total Common Equity | 115.63 | -8.21 | -14.44 | 21.57 | 10.72 | 37.84 | Upgrade
|
| Shareholders' Equity | 115.63 | -8.21 | -14.44 | 21.57 | 10.72 | 37.84 | Upgrade
|
| Total Liabilities & Equity | 162.33 | 67.03 | 47.49 | 75.33 | 60.42 | 68.98 | Upgrade
|
| Total Debt | 3.94 | 4.88 | 1.21 | 5.06 | 7.96 | 11.73 | Upgrade
|
| Net Cash (Debt) | 123.44 | 30.9 | 31.52 | 54.62 | 27.95 | 38.54 | Upgrade
|
| Net Cash Growth | 178.57% | -1.96% | -42.29% | 95.42% | -27.48% | -40.37% | Upgrade
|
| Net Cash Per Share | 24.48 | 7.07 | 9.02 | 20.83 | 13.45 | 25.75 | Upgrade
|
| Filing Date Shares Outstanding | 7.05 | 4.56 | 4.45 | 3.41 | 2.4 | 2.03 | Upgrade
|
| Total Common Shares Outstanding | 7.05 | 4.53 | 3.62 | 3.39 | 2.24 | 1.69 | Upgrade
|
| Working Capital | 112.43 | -6.56 | 3.69 | 37.68 | 18.63 | 35.62 | Upgrade
|
| Book Value Per Share | 16.41 | -1.81 | -3.98 | 6.36 | 4.78 | 22.36 | Upgrade
|
| Tangible Book Value | 115.63 | -8.21 | -14.44 | 21.57 | 10.72 | 37.84 | Upgrade
|
| Tangible Book Value Per Share | 16.41 | -1.81 | -3.98 | 6.36 | 4.78 | 22.36 | Upgrade
|
| Machinery | - | 3.32 | 2.96 | 3.06 | 2.97 | 2.85 | Upgrade
|
| Leasehold Improvements | - | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.